REC-1819

N/A

Report date: 2022/08/31 17:50:41
NME

Base Information

Drug NameREC-1819
Drug Alias NameREC-1819
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCentral nervous system modulators
TargetsNot applicable
Therapy Area/IndicationsUrinary IncontinenceUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRecordati
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecordati
Active IndicationsN/A
Inactive IndicationsUrinary IncontinenceUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A